In endometrial carcinoma, the CD4+/CD8+ TILs ratio has been reported to be significantly associated with expression of immune checkpoint proteins such as cytotoxic T-lymphocyte associated protein 4(CTLA-4) and PD-L1 [35]. Here, CD8A is linked to endometrial carcinoma.